P/E ratio for Cardinal Health (CAH)
P/E ratio as of June 2025 (TTM): 25.5
According to Cardinal Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.5381. At the end of 2024 the company had a P/E ratio of 21.9.
P/E ratio history for Cardinal Health from 2001 to 2025
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2024 | 21.9 | -44.27% |
| 2023 | 39.4 | -337.16% |
| 2022 | -16.6 | -161.91% |
| 2021 | 26.8 | 136.83% |
| 2020 | 11.3 | -419.24% |
| 2019 | -3.55 | -99.52% |
| 2018 | -743 | -7124.48% |
| 2017 | 10.6 | -38.25% |
| 2016 | 17.1 | -20.34% |
| 2015 | 21.5 | -12.87% |
| 2014 | 24.7 | -59.35% |
| 2013 | 60.7 | 391.14% |
| 2012 | 12.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 AmerisourceBergen
ABC | 21.7 | -14.99% | 🇺🇸 USA |
 McKesson MCK | 32.8 | 28.53% | 🇺🇸 USA |
 Henry Schein
HSIC | 22.4 | -12.16% | 🇺🇸 USA |
 CVS Health CVS | 16.1 | -36.99% | 🇺🇸 USA |
 Herbalife HLF | 3.02 | -88.18% | 🇺🇸 USA |
 Patterson Companies
PDCO | 20.1 | -21.36% | 🇺🇸 USA |
 Owens & Minor
OMI | -1.57 | -106.17% | 🇺🇸 USA |
 Premier PINC | -62.1 | -343.33% | 🇺🇸 USA |
 Veradigm MDRX | 9.00 | -64.76% | 🇺🇸 USA |
 Teleflex TFX | 37.4 | 46.50% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.